Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Antares Vision acquires 100 per cent of Convel, further diversifying its inspection machine…
Convel specializes in inspection equipment providing leak detection for pharmaceutical products packaged in glass and plastic…
China gives the go-ahead for human trials of BioNTech’s COVID vaccine candidate
The potential vaccine is one of the two most advanced candidates that BioNTech is working on with its partner Pfizer and they…
Arab Pharma Manufacturers’ Expo 2020 to be organised virtually in September
The most unique feature of the Arab Pharma Manufacturers' Expo (Virtual Exhibition) is incorporation of a complete spectrum of…
Zydus receives approval from COFEPRIS to conduct clinical trials for COVID-19 treatment therapy
Zydus had earlier approached the DCGI to investigate the role of Pegylated Interferon alpha-2b for COVID 19 and the clinical…
China’s Sinopharm begins late stage trial of COVID-19 vaccine in UAE
The human trial is a partnership between Sinopharm’s China National Biotec Group (CNBG), Abu Dhabi-based artificial intelligence…
J&J in talks with Japan, Gates Foundation to lock in deals on COVID-19 vaccine
J&J has already agreed to prioritize an allocation to the United States as part of its funding agreement with the U.S.…
World’s first phase III clinical trial of COVID-19 inactivated vaccine begins in UAE
H.E. Sheikh Abdullah bin Mohammed Al Hamed, Chairman of Department of Health, Abu Dhabi is the first to participate in the…
Greater global cooperation needed to tackle vaccine-preventable diseases in a world with COVID-19
The study included researchers from the University of Strathclyde, University of Ghana, Imperial College London, the Center for…
Indian pharma industry can produce COVID-19 vaccines for entire world: Bill Gates
Highlighting Gates Foundation's role in India’s war against coronavirus, he said that it has been funding work on detection and…
Guidelines for PLI scheme, bulk drug parks to be out by next week: Jt Secy, DoP
State governments may get two months to submit their proposals for the bulk drug parks while pharma companies will get…